Selective cardiac plasma-membrane KATP channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion

European Journal of Pharmacology

Volumn 577, Issue 1-3, 2007, Pages 115-123

  Vajda, Szilvia ^a   Baczkó, István ^a   Leprán, István ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

5 hydroxy decanoate; Glibenclamide; HMR 1883; Sarcolemmal KATP channels; Ventricular arrhythmias

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; CLAMIKALANT; GLIBENCLAMIDE; PENTOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; RAT; REPERFUSION INJURY; SURVIVAL RATE;

ACUTE DISEASE; ANESTHESIA; ANIMALS; ANTI-ARRHYTHMIA AGENTS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CELL MEMBRANE; DECANOIC ACIDS; ELECTROCARDIOGRAPHY; GLYBURIDE; HEART; HYDROXY ACIDS; KATP CHANNELS; MALE; ORGAN SPECIFICITY; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SARCOLEMMA; SULFONAMIDES; SURVIVAL; THIOUREA; VENTRICULAR FIBRILLATION;

EID: 35449004964     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.08.016     Document Type: Article

References (49)

1. Aguilar-Bryan L., and Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr. Rev. 20 (1999) 101-135
2. ATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats. Eur. J. Pharmacol. 324 (1997) 77-83
3. Billman G.E., Avendano C.E., Halliwill J.R., and Burroughs J.M. The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs. J. Cardiovasc. Pharmacol. 21 (1993) 197-204
4. Billman G.E., Englert H.C., and Scholkens B.A. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J. Pharmacol. Exp. Ther. 286 (1998) 1465-1473
5. Chi L.G., Tamura Y., Hoff P.T., Macha M., Gallagher K.P., Schork M.A., and Lucchesi B.R. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 h of regional ischemia and reperfusion: a demonstration of myocardial salvage. Circ. Res. 64 (1989) 665-675
6. + channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 69 (1991) 571-581
7. + channels and free radicals. J. Cardiovasc. Pharmacol. 41 (2003) 916-922
8. ATP channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?. Life Sci. 77 (2005) 1226-1248
9. del Valle H.F., Lascano E.C., Negroni J.A., and Crottogini A.J. Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep. Cardiovasc. Res. 50 (2001) 474-485
10. K.ATP blockers glibenclamide and HMR1883 on cardiac electrophysiology during ischemia and reperfusion. Eur. J. Pharmacol. 398 (2000) 273-284
11. El Reyani N.E., Bozdogan O., Baczko I., Lepran I., and Papp J.G. Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats. Eur. J. Pharmacol. 365 (1999) 187-192
12. Englert H.C., Heitsch H., Gerlach U., and Knieps S. Blockers of the ATP-sensitive potassium channel SUR2A/Kir6.2: a new approach to prevent sudden cardiac death. Curr. Med. Chem. Cardiovasc. Hematol. Agents 1 (2003) 253-271
13. Farkas A., and Curtis M.J. Does QT widening in the Langendorff-perfused rat heart represent the effect of repolarization delay or conduction slowing?. J. Cardiovasc. Pharmacol. 42 (2003) 612-621
14. ATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide. Cardiovasc. Res. 30 (1995) 781-787
15. + channels. J. Biol. Chem. 263 (1988) 7933-7936
16. Friedrichs G.S., Abreu J.N., Black S.C., Chi L., and Lucchesi B.R. 5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death. Eur. J. Pharmacol. 306 (1996) 99-106
17. Gögelein H., Hartung J., Englert H.C., and Scholkens B.A. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: effects on cardiomyocytes, coronary flow and pancreatic beta-cells. J. Pharmacol. Exp. Ther. 286 (1998) 1453-1464
18. Gok S., Vural K., Sekuri C., Onur R., Tezcan A., and Izanli A. Effects of the blockade of cardiac sarcolemmal ATP-sensitive potassium channels on arrhythmias and coronary flow in ischemia-reperfusion model in isolated rat hearts. Vasc. Pharmacol. 44 (2006) 197-205
19. Hanley P.J., Drose S., Brandt U., Lareau R.A., Banerjee A.L., Srivastava D.K., Banaszak L.J., Barycki J.J., Van Veldhoven P.P., and Daut J. 5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids. J. Physiol. 562 (2005) 307-318
20. Hayes E., Pugsley M.K., Penz W.P., Adaikan G., and Walker M.J. Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates. J. Pharmacol. Toxicol. Methods. 32 (1994) 201-207
21. Hearse D.J. Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection?. Cardiovasc. Res. 30 (1995) 1-17
22. Huikuri H.V., Castellanos A., and Myerburg R.J. Sudden death due to cardiac arrhythmias. N. Engl. J. Med. 345 (2001) 1473-1482
23. KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270 (1995) 1166-1170
24. + channels. Neuron 16 (1996) 1011-1017
25. Janse M.J., and Wit A.L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev. 69 (1989) 1049-1169
26. Kawano T., Oshita S., Takahashi A., Tsutsumi Y., Tomiyama Y., Kitahata H., Kuroda Y., and Nakaya Y. Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 100 (2004) 338-346
27. Kecskemeti V., Bagi Z., Pacher P., Posa I., Kocsis E., and Koltai M.Z. New trends in the development of oral antidiabetic drugs. Curr. Med. Chem. 9 (2002) 53-71
28. Kita H., Miura T., Tsuchida A., Hasegawa T., and Shimamoto K. Suppression of reperfusion arrhythmias by preconditioning is inhibited by an ATP-sensitive potassium channel blocker, 5-hydroxydecanoate, but not by protein kinase C blockers in the rat. J. Cardiovasc. Pharmacol. 32 (1998) 791-797
29. Lepran I., Koltai M., Siegmund W., and Szekeres L. Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. J. Pharmacol. Methods 9 (1983) 219-230
30. Lepran I., Baczko I., Varro A., and Papp J.G. ATP-sensitive potassium channel modulators: both pinacidil and glibenclamide produce antiarrhythmic activity during acute myocardial infarction in conscious rats. J. Pharmacol. Exp. Ther. 277 (1996) 1215-1220
31. Light P.E., Kanji H.D., Fox J.E., and French R.J. Distinct myoprotective roles of cardiac sarcolemmal and mitochondrial KATP channels during metabolic inhibition and recovery. FASEB J. 15 (2001) 2586-2594
32. ATP channels. Mol. Pharmacol. 59 (2001) 225-230
33. + channels involves high-energy phosphate preservation. Am. J. Physiol. 265 (1993) H1809-H1818
34. Nachlas, M.M., Shnitka, T.K., 1963. Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am. J. Pathol. 42, 379-405., 379-405.
35. + channels reconstituted in lipid bilayers. Am. J. Physiol, Heart Circ. Physiol. 284 (2003) H1865-H1871
36. Niho T., Notsu T., Ishikawa H., Funato H., Yamazaki M., Takahashi H., Tanaka I., Kayamoto M., Dabasaki T., Yamasaki F., et al. Study of mechanism and effect of sodium 5-hydroxydecanoate on experimental ischemic ventricular arrhythmia. Nippon Yakurigaku Zasshi. 89 (1987) 155-167
37. + channels in cardiac muscle. Nature. 305 (1983) 147-148
38. Piper H.M., Abdallah Y., and Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc. Res. 61 (2004) 365-371
39. Rees S.A., and Curtis M.J. Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate. Circulation 87 (1993) 1979-1989
40. + channels by protein kinase C. Circ. Res. 83 (1998) 110-114
41. Schaffer P., Pelzmann B., Bernhart E., Lang P., Machler H., Rigler B., and Koidl B. The sulphonylurea glibenclamide inhibits voltage dependent potassium currents in human atrial and ventricular myocytes. Br. J. Pharmacol. 128 (1999) 1175-1180
42. Stadnicka A., and Bosnjak Z.J. Isoflurane decreases ATP sensitivity of guinea pig cardiac sarcolemmal KATP channel at reduced intracellular pH. Anesthesiology 98 (2003) 396-403
43. Varro A., Lathrop D.A., Hester S.B., Nanasi P.P., and Papp J.G. Ionic currents and action potentials in rabbit, rat, and guinea pig ventricular myocytes. Basic Res. Cardiol. 88 (1993) 93-102
44. Verkerk A.O., Veldkamp M.W., van Ginneken A.C., and Bouman L.N. Biphasic response of action potential duration to metabolic inhibition in rabbit and human ventricular myocytes: role of transient outward current and ATP-regulated potassium current. J. Mol. Cell. Cardiol. 28 (1996) 2443-2456
45. Walker M.J., Curtis M.J., Hearse D.J., Campbell R.W., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness J.B., Harron D.W., et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc. Res. 22 (1988) 447-455
46. Wilde A.A., and Janse M.J. Electrophysiological effects of ATP sensitive potassium channel modulation: implications for arrhythmogenesis. Cardiovasc. Res. 28 (1994) 16-24
47. Wirth K.J., Klaus E., Englert H.G., Scholkens B.A., and Linz W. HMR 1883, a cardioselective K(ATP) channel blocker, inhibits ischaemia- and reperfusion-induced ventricular fibrillation in rats. Naunyn-Schmiedebergs Arch. Pharmacol. 360 (1999) 295-300
48. ATP channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigs. Naunyn-Schmiedebergs Arch. Pharmacol. 361 (2000) 155-160
49. - channels in mammalian cardiac myocytes. Circ. Res. 81 (1997) 101-109